Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ODC1 | P11926 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43474 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL203118 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL2639323 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL202447 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL12775011 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL19107453 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL23765660 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL14745208 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL19107454 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 | |
| SCHEMBL13079441 | 1.00 | MEN1 (0.38) | MEN1KMT2AODC1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190352625-A1 | MUTANTS OF COCAINE ESTERASE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2019-11-21 | — | — | US | claimed |
| US-10160960-B2 | Mutants of cocaine esterase | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2018-12-25 | — | — | US | claimed |
| US-20160177277-A1 | MUTANTS OF COCAINE ESTERASE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-06-23 | — | — | US | claimed |
| US-11466063-B2 | Conjugated knottin mini-proteins containing non-natural amino acids | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-10-11 | — | — | US | disclosed |
| US-20220211035-A1 | METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES | SILICON VALLEY BANK (CA) | 2022-07-07 | — | — | US | disclosed |
| US-11289238-B2 | Compositions for the filling of high aspect ratio vertical interconnect access (VIA) holes | HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC (US) | 2022-03-29 | — | — | US | disclosed |
| EP-3378310-B1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE CROP PROT INC (CA) | 2021-08-04 | — | — | EP | disclosed |
| US-20210174983-A1 | COMPOSITIONS FOR THE FILLING OF HIGH ASPECT RATIO VERTICAL INTERCONNECT ACCESS (VIA) HOLES | HERAEUS PRECIOUS METALS NORTH AMERICA CONSHOHOCKEN LLC | 2021-06-10 | — | — | US | disclosed |
| US-20200260724-A1 | METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES | SILICON VALLEY BANK (CA) | 2020-08-20 | — | — | US | disclosed |
| US-20200239531-A1 | CONJUGATED KNOTTIN MINI-PROTEINS CONTAINING NON-NATURAL AMINO ACIDS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
| US-20190352625-A1 | MUTANTS OF COCAINE ESTERASE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2019-11-21 | — | — | US | disclosed |
| US-20130296606-A1 | PRECURSOR OF POLYMERIZABLE COMPOUND | FUJIFILM CORPORATION (JP) | 2013-11-07 | — | — | US | disclosed |
| US-20130130904-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE CROP PROTECTION INC. (CA) | 2013-05-23 | — | — | US | disclosed |
| US-20130034650-A1 | METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES | VIVE CROP PROTECTION INC. (CA) | 2013-02-07 | — | — | US | disclosed |
| US-20120065071-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE NANO, INC. (CA) | 2012-03-15 | — | — | US | disclosed |
| US-8084397-B2 | Methods to produce polymer nanoparticles and formulations of active ingredients | VIVE NANO, INC. (CA) | 2011-12-27 | — | — | US | disclosed |
| US-20100210465-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE NANO, INC. (CA) | 2010-08-19 | — | — | US | disclosed |
| US-20090246285-A1 | MONODISPERSED ORGANIC MONOLAYER COATED CALCIUM-CONTAINING NANOPARTICLES | STELLACCI FRANCESCO | 2009-10-01 | — | — | US | disclosed |
| WO-2009111437-A2 | MONODISPERSED ORGANIC MONOLAYER COATED CALCIUM-CONTAINING NANOPARTICLES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-09-11 | — | — | WO | disclosed |
| US-20080124776-A1 | Carbodithioate Ligands For Nanotechnology and Methods of Use | NATIONAL SCIENCE FOUNDATION | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296606-A1 | PRECURSOR OF POLYMERIZABLE COMPOUND | NRAS, KRAS, KSR1 | MEN1 819/4885KMT2A 2586/4885ODC1 2610/4885 |
| US-11466063-B2 | Conjugated knottin mini-proteins containing non-natural amino acids | ECPAS, ATRIP, ANPEP | MEN1 3025/4885KMT2A 693/4885ODC1 2273/4885 |
| US-20200239531-A1 | CONJUGATED KNOTTIN MINI-PROTEINS CONTAINING NON-NATURAL AMINO ACIDS | ECPAS, ATRIP, ANPEP | MEN1 3025/4885KMT2A 693/4885ODC1 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.